|
2024
|
Invention
|
Modified h3 hemagglutinin antigens and methods of use thereof. Disclosed herein are immune focuse... |
|
|
Invention
|
Optimized nucleic acid antibody constructs.
Disclosed herein are compositions comprising structu... |
|
|
Invention
|
Non-neutralizing aav constructs and methods of generating and using same. Provided are engineered... |
|
|
Invention
|
Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and a parp inhibitor.
Ther... |
|
|
Invention
|
Vaccines against african swine fever virus, and methods of using same. An aspect of the present i... |
|
|
Invention
|
Dna antibody constructs for use against middle east respiratory syndrome coronavirus.
Disclosed ... |
|
|
Invention
|
Structure-based optimization of s6k2 inhibitor cd02 to target melanoma. Disclosed herein are comp... |
|
|
Invention
|
Compositions comprising aptamers and methods of modulating the immune response using the same. Th... |
|
|
Invention
|
Combination therapies targeting mitochondria for cancer therapy.
Pharmaceutical compositions for... |
|
|
Invention
|
Adar1 inhibitors and uses thereof. Provided herein are ADAR1 inhibitors and methods of treating c... |
|
|
Invention
|
Methods and compositions for diagnosis of ectopic pregnancy. Methods and compositions are provide... |
|
|
Invention
|
Methods and compositions for diagnosis of ectopic pregnancy, intrauterine pregnancy, and spontane... |
|
|
Invention
|
Tri-specific t-cell engagers and methods of use in cancer therapeutics. The invention provides co... |
|
|
Invention
|
Glycan modified sars-cov-2 glycoprotein nanoparticles and methods of use thereof. Disclosed herei... |
|
|
Invention
|
Mage-a vaccines and methods of treatment using the same.
Disclosed herein are compositions and m... |
|
|
Invention
|
Nanoparticle compositions and uses thereof for reactivation of latent hiv. Provided herein are na... |
|
|
Invention
|
Epitope editing and multi-specific immunce-cell engager therapy and methods of use. Disclosed her... |
|
|
Invention
|
Antibody-cytokine chimeras. Disclosed herein are antibody cytokine chimeras, nucleic acid molecul... |
|
|
Invention
|
Dna monoclonal antibodies targeting checkpoint molecules.
Disclosed herein is a composition incl... |
|
|
Invention
|
Glycoprotein d variants as vaccine adjuvants.
Disclosed herein are compositions for increasing t... |
|
|
Invention
|
Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-... |
|
|
Invention
|
Ebna1 inhibitors and methods using same.
The present invention provides EBNA1 inhibitors, and/or... |
|
|
Invention
|
Glycoprotein d variants as vaccine adjuvants. Disclosed herein are compositions for increasing th... |
|
|
Invention
|
Mdm2 targeting protacs. Disclosed herein are compounds of the formulas: (I) as well as analogs th... |
|
2023
|
Invention
|
Siglec 9 inhibitors and methods of use thereof for enhancing immunotherapy efficacy. Disclosed he... |
|
|
Invention
|
Compositions and methods for identification of hypomorphic p53 variants. Compositions and uses th... |
|
|
Invention
|
Systems and methods for identifying novel and divergent viruses in transcriptomes.
Systems and m... |
|
|
Invention
|
Hiv immunogens and methods of using same. Disclosed are HIV immunogens as well as nucleic acids e... |
|
|
Invention
|
Combination therapies targeting mitochondrial biogenesis for cancer therapy.
Pharmaceutical comp... |
|
|
Invention
|
Brisc deubiquitinating enzyme inhibitors. The present disclosure provides for techniques using BR... |
|
|
Invention
|
Dna monoclonal antibodies targeting influenza virus.
Disclosed herein is a composition including... |
|
|
Invention
|
Fenofibrate improves t-cell therapies. Provided herein is a method for treating cancer comprising... |
|
|
Invention
|
Compositions comprising neoantigens and methods of enhancing anti-pd1 therapy. The disclosure rel... |
|
|
Invention
|
Inhibition of kdm5a for promoting antigen presentation, increasing cd8+ t cell infiltration and b... |
|
|
Invention
|
Substituted chromenones, ire1 inhibitors, and methods of using same.
The present invention inclu... |
|
|
Invention
|
Combination of novel vaccines against zika virus and dna antibody constructs for use against zika... |
|
|
Invention
|
Methods and compositions for treating cancers by inhibiting estrogen signaling in myeloid-derived... |
|
2022
|
Invention
|
Bispecific immune cell engagers targeting hiv and methods of use thereof.
Disclosed herein are c... |
|
|
Invention
|
Dna encoded antibodies with fc modifications.
Disclosed herein are nucleic acid encoded Fc-modif... |
|
|
Invention
|
Antibodies for use against sars-cov-2.
Disclosed herein are antibodies to SARS-COV-2 antigens an... |
|
|
Invention
|
Novel immune cell engagers for immunotherapy.
The present invention provides natural killer enga... |
|
|
Invention
|
Bispecific t-cell engagers targeting fshr and methods of use in cancer theraputics.
Disclosed he... |
|
|
Invention
|
Synthetic dna vaccine immunogenic improvements.
Disclosed herein is a composition comprising one... |
|
|
Invention
|
Glycan modified spike receptor binding domain nanoparticles and method of use thereof as a corona... |
|
|
Invention
|
Sialydase linked hiv antibodies and methods of use.
Disclosed herein are compositions for target... |
|
|
Invention
|
Dna encoded nanoparticle vaccine against human papillomavirus, and methods of use thereof.
Discl... |
|
|
Invention
|
Dna-encoded bispecific antibodies targeting il13ra2 and methods of use in cancer therapeutics.
D... |
|
|
Invention
|
Adenovirus sars-cov-2 vaccine.
The present invention includes methods and compositions useful fo... |
|
|
Invention
|
Compounds and methods for preventing, treating, or ameliorating airway disease.
The β2-adrenergi... |
|
2021
|
Invention
|
Compositions comprising self-assembling vaccines and methods of using the same.
The disclosure g... |
